<DOC>
	<DOC>NCT00189254</DOC>
	<brief_summary>The purpose of the study is to obtain recurrence rates and long-term safety data for patients who had been treating actinic keratoses on the face and scalp with 5 % Imiquimod Cream in a previous study.</brief_summary>
	<brief_title>A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>100% clearance of Actinic Keratosis (AK) lesions in the 1487 IMIQ study used any treatments in the previous treatment area within 24 hours prior to the followup visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>1 year follow up</keyword>
</DOC>